Synthesis and pharmacological evaluation of m-terphenyl amines as cyclooxygenase inhibitors
- 245 Downloads
A series of m-terphenyl amines was synthesized and evaluated as a novel class of cyclooxygenase (COX) inhibitors. Structure–activity relationships (SAR) were investigated by functional group modification at the para-position of the C-1′ and C-2′ phenyl substituents on the central aromatic ring. Anilines 6a, b, d, and h demonstrated nonselective inhibition of COX-1 and -2 in human whole blood. Compounds 6c and e demonstrated preferential inhibition of the COX-2 isozyme at 10 μM. Molecules 6f, i, and j inhibited only COX-1, and the disubstituted ethoxy derivative (6g) was inactive as a COX inhibitor (≤ 100 μM). Molecular docking studies of these compounds indicate that the COX-1 binding site amino acid Ile523 anchors the m-terphenyl system statically within the enzyme’s active site, while the slightly smaller amino acid Val523 in COX-2 allows the ligand to “roll,” fashioning several acceptable conformers.
- Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, Day R, Ferraz M, Hawkey CJ, Hochberg MC, Kvien TK, Schnitzer TJ (2000) Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group N Engl J Med 343:1520–1528CrossRefGoogle Scholar
- Botting RM, Botting JH (2004) The discovery of COX-2. In: Pairet M, van Ryn J (eds) Milestones in Drug Therapy: COX-2 Inhibitors. Birkhaeuser, Switzerland, pp 1–13Google Scholar
- Degner F (2004) Efficacy and gastrointestinal safety of selective COX-2 inhibitors. In: Pairet M, van Ryn J (eds) Milestones in Drug Therapy: COX-2 Inhibitors. Birkhauser, Switzerland, pp 133–148Google Scholar
- Seibert K, Masferrer JL, Jiyi F, Hond A, Raz A, Needleman P (1990) The biochemical and pharmacological manipulation of cellular cyclooxygenase (COX) activity. Adv Prostaglandin Thromboxane Leukotriene Res 21:45–51Google Scholar
- Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 231:232–235Google Scholar